FDA panel rejects drug for Duchenne muscular dystrophy

[Who Me?]

In a confrontation between the hopes of desperate patients and clinical trial data, advisers to the Food and Drug Administration voted on Monday not to recommend approval of what would become the first drug for Duchenne muscular dystrophy.

http://mobile.nytimes.com/2016/04/2...eplirsen.html?referer=https://www.google.com/